Neurological abnormalities and cognitive ability in first-episode psychosis

British Journal of Psychiatry

Volumn 193, Issue 3, 2008, Pages 197-202

  Dazzan, Paola ^a   Lloyd, Tuhina ^b   Morgan, Kevin D ^a   Zanelli, Jolanta ^a   Morgan, Craig ^a   Orr, Ken ^a   Hutchinson, Gerard ^a   Fearon, Paul ^a   Allin, Matthew ^a   Rifkin, Larry ^a   McGuire, Philip K ^a   Doody, Gillian A ^b   Holloway, John ^c   Leff, Julian ^a   Harrison, Glynn ^c   Jones, Peter B ^d   Murray, Robin M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ETHNICITY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOTOR COORDINATION; NEUROLOGIC EXAMINATION; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE;

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; CASE-CONTROL STUDIES; COGNITION DISORDERS; ENGLAND; FEMALE; HUMANS; INTELLIGENCE; MALE; NEUROLOGIC EXAMINATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS;

EID: 51449090325     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.045450     Document Type: Article

References (38)

1. Buchanan RW, Heinrichs DW. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27: 335-50.
2. Dazzan P, Murray RM. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 2002; 181 (suppl 43): S50-7.
3. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry 1999; 156: 1349-57.
4. Mohr F, Hubmann W, Albus M, Franz U, Hecht S, Scherer J, Binder J, Sobizack N. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Res 2003; 121: 21-30.
5. Flashman LA, Flaum M, Gupta S, Andreasen NC. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry 1996; 153: 526-32.
6. King DJ, Wilson A, Cooper SJ, Waddington JL. The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry 1991; 158: 770-5.
7. Kirkbride JB, Fearon P, Morgan C, Dazzon P, Morgan K, Tarrant J, Lloyd T, Holloway J, Hutchinson G, Leff JP, Mallet RM, Harrison GL, Murray RM, Jones PB. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 2006; 63: 250-8.
8. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
9. Morgan C, Dazzan P, Morgan K, Jones P, Harrison G, Leff J, Murray K, Fearon P; AESOP study group. First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry 2006; 5: 40-6.
10. Bebbington P, Nayani T. The Psychosis Screening Questionnaire. Int J Methods Psychiatr Res 1995; 5: 11-9.
11. World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry (SCAN) - Version 2.0. WHO, 1992.
12. Wing JK, Cooper JE, Sartorius N. The Measurement and Classification of Psychiatric Symptoms. Cambridge University Press, 1974.
13. Wing JK, Sturt E. The PSE-ID-CATEGO System: Supplementary Manual. Medical Research Council, 1978.
14. World Health Organization. Personal and Psychiatric History Schedule. WHO, 1996.
15. Nelson HE, Willison JR. National Adult Reading Test (part II) Test Manual. nferNelson, 1991.
16. Wechsler D. Wechsler Adult Intelligence Scale - Revised (Manual). The Psychological Corporation, 1981.
17. Annett M. A classification of hand preference by association analysis. Br J Psychol 1970; 61: 303-21.
18. Griffiths TD, Sigmundsson T, Takei N, Rowe D, Murray RM. Neurological abnormalities in familial and sporadic schizophrenia. Brain 1998; 121: 191-203.
19. Sanders RD, Keshavan MS, Forman SD, Pieri JN, McLaughlin N, Allen DN, van Kammen DP, Goldstein G. Factor structure of neurologic examination abnormalities in unmedicated schizophrenia. Psychiatry Res 2000; 95: 237-43.
20. Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis x, Suckling J, Fearon P, Salvo J, McGuire PK, Mallet RM, Jones PB, Leff J, Murray RM. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 2004; 127: 143-53.
21. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212: 11-9.
22. Barnes TRE. A rating scale for drug induced akathisia. Br J Psychiatry 1989; 154: 676.
23. National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). In ECDEU: Assessment Manual for Psychopharmacology (ed W Guy): 534-7. Department of Health, Education and Welfare, 1976.
24. Browne S, Clarke M, Gervin M, Lane A, Waddington JL, Larkin C, O'Callaghan E. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med 2000; 30: 1433-41.
25. Emsley R, Turner HJ, Oosthuizen PP, Carr J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophr Res 2005; 75: 35-44.
26. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand 1999; 100: 119-25.
27. Cox SM, Ludwig AM. Neurological soft signs and psychopathology. I. Findings in schizophrenia. J Nerv Ment Dis 1979; 167: 161-5
28. Goswami U, Sharma A, Khastigir U, Ferrier IN, Young AH, Gallagher P, Thompson JM, Moore PB. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry 2006; 188: 366-73.
29. Whitty P, Clarke M, McTigue O, Browne S, Gervin M, Kamali M, Lane A, Knsella A, Waddington J, Larkin C, O'callaghan E. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophr Res 2006; 86: 110-7.
30. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, Schooler NR. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 2003; 160: 1298-304.
31. Ho BC, Mola C, Andreasen NC. Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biol Psychiatry 2004; 55: 1146-53.
32. Mohr F, Hubmann W, Cohen R, Bender W, Haslacher C, Hönicke S, Schlenker R, Wahheim C, Werther P. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci 1996; 246: 240-8.
33. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry 1994; 151: 1231-3
34. Venkatasubramanian G, Latha v, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, Keshavan MS. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand 2003; 108: 144-6.
35. Yazici AH, Demir B, Yazici KM, Gogus A. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr Res 2002; 58: 241-6.
36. Lawrie SM, Byrne M, Miller P, Hodges A, Clafferty RA, Cunningham Owen DG, Johnson EC Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry 2001; 178: 524-30.
37. Cuesta MJ, Peralta V, Zarzuela A, Calvo R, Garcia M, Serrano F. Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophr Res 2002; 58: 263-71.
38. Dazzan P, Morgan KD, Chitnis x, Suckling J, Morgan C, Fearon P, McGuire PK, Jones PB, Leff J, Murray RM. The structural brain correlates of neurological soft signs in healthy individuals. Cereb Cortex 2005; 16: 1225-31.